chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a nurse refers to multiple unspecified patients of unknown age and gender. On unknown dates the patients were vaccinated with unspecified improperly stored PNEUMOVAX 23 (lot # M000592, expiration date 12-OCT-2017). The vaccines were exposed to 9.7 degrees centigrade for a cumulative time frame of 4 hours and 41 minutes. There was no previous excursion. This report was for data logger. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Red rash on face, head, neck, chest and back. Was itchy to him, had a little fever (99.6) and was warm to the touch.
Dizziness, brain fog, fatigue, sore and swollen arm with raised red, hot lump, nausea
Spoke to Pt who states has had red/brown spots on face and hands on/off since beginning of May. Pt states spots started approx 1 week after getting Covid vaccine on 4/24. Pt denies pain, itching, bleeding. Pt states they start off red then change colors and sometimes skin peels off.
Following vax, the pt experienced a lump in throat and felt flushed all over. Within a few minutes, the pt began to clear throat, voice was hoarse, had trouble breathing and talking. The pt was in a supine position and had an occasional faint wheeze. Pt was given adrenaline. After 30 minutes the pt returned to work.
Night of vaccine, experienced involuntary muscle twitching of extremities.  Continued for approximately 1.5 weeks when laying down at night to sleep.  1 week after vaccine woke up with rash at vaccination site and sore armpit (felt like swollen glands in armpit).  Red and itchy rash grew to size of softball next couple of days, armpit became more sore.  Rash and armpit soreness improved over next week, and now 95% better.
Facial itching eye swelling  wheezing- occurrred on two incidences treated with Benadryl and nexium first episode. Second episode was seen by dr - dose pack, famotidine, Benadryl, rescue inhaler were prescribed..
Loss of taste and smell: Fluticasone propionate. Elevated blood pressure: Olmesartan.
This is a spontaneous case, initially received on 24-Jan-2018 from other health professional concerning a 12-year-old, adolescent, female patient. On an unspecified date in Dec-2017, the vaccine underwent first temperature excursion. It was reported that, FLUCELVAX Quadrivalent PFS had been out of range for 80 hours, reaching the highest temperature of 9.1 C (explicitly coded as incorrect product storage). On 21-Dec-2017, the patient was administered with FLUCELVAX QIV after the first temperature excursion (dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid (reported as right or left deltoid), batch number: 195228, expiry date: 31-May-2018) (explicitly coded as drug administration error). It was reported that, the patient did not experience any adverse event following vaccination. The reporter assessed the events (incorrect product storage and drug administration error) as non-serious. Significant case correction received 24-Jan-2018: Added start date of the event (incorrect product storage) as Dec-2017 in the product tab.
positive rash/hives, edema of lips, pruritis - severe; I used Benadryl from 11/14 till 11/26;  From 11/19 to 11/26 took Methlyprednisolone
two bouts of shingles; sick, down for two days; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included MMR (MMR vaccine) for prophylaxis.   The patient's past medical history included chickenpox (had chicken pox in 30s). Concurrent medical conditions included autoimmune disorder (already immunosuppressed).   On an unknown date, the patient received the 1st dose of Shingles vaccine and MMR vaccine. On an unknown date, unknown after receiving Shingles vaccine and MMR vaccine, the patient experienced shingles and sickness. On an unknown date, the outcome of the shingles was unknown and the outcome of the sickness was recovered/resolved.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine and MMR vaccine. The reporter considered the sickness to be related to Shingles vaccine and MMR vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient enquired if shingles vaccine makes sick as the patient got the shingle shot and was down for two days and had two bouts of shingles in his/her late/early 40s/50s. The patient hoped that it was because as he/she had it along with my MMR vaccine and that it was that causing him/her to get sick. The patient was supposed to get his/her second one in a few months. Note: Shingles was conservatively captured as event as it was unclear when shingles took place after or before Shingles vaccination.
stabbing pain in eye; stye forming; ulceration under eyelid; pinky toe; Headache; Earache; Swollen gland in neck; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non pregnant female patient received the first dose BNT162b2 (PFIZER- BIONTECH COVID-19 m RNA vaccine, lot no: EN6203) via an unspecified route of administration in the left arm on 06Mar2021 at 06:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medications within 2 weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 07Mar2021 at 18:00 the patient had experienced headache, earache, glands swollen and on 14Mar2021, she had pinky toe, stabbing pain in eye, stye forming which followed by ulceration under eyelid. It was reported that all events occurred on left side of body and lasted for 2 days moving from a different area each time. Adverse events resulted in the doctor or other healthcare professional office/clinic visit. The patient was treated with gentamicin for the reported events. The patient underwent COVID-19 virus test post vaccination, which included SARS-CoV-2 RT PCR (Nasal swab) test on 15Mar2021 and the result was found to be negative. The clinical outcome of the events headache, earache, swollen gland in neck, pinky toe, stabbing pain in eye, stye forming and ulceration under eyelid was resolved in Mar2021.   No follow-up attempts are needed. No further information is expected.
All of patient's upper arm, where vaccine was administered, became red and swollen.  Remained so for 4-5 days.
Felt warm, dizzy  & nauseated.  Gave cold pac, elevated legs, & fanned.  Recovered within 20 min.
Chills, NV, sore arms, burning sensation w/pneumonia shot, IV fluids.
The day after my 4th dose, I had a rash on my arm, face, legs. My arm was red and I had blotches and a blister on my face. I immediately took BENADRL and within a few days it went away.
Unsure, Department followed up on her positive COVID results in 10/2020 and 11/2020.  It came to our attention last week that the reason stated for her death on 5/28/21 was due to COVID.  Due to having 2 positive tests late last fall and then seeing that she had been vaccinated for COVID in March and April 2021, I was instructed to complete a VAERS.
the patient had the second dose of Moderna vaccine and monitored in the pharmacy for 15 minutes, the husband said on Saturday ( next day), she wasn't feeling ok the blood pressure dropped to 73/46. She went to the hospital and the doctors thought it might be an interaction happened between the vaccine and one of her kidney transplant rejection. The husband didn't know the name of the medication. Then she was ok and discharged from the hospital on Monday 5/3/21
C/O myalgias of back, chest, legs & arms c/o arthralgias of PIP joints of fingers, bil knees, sx began the evening of 11/12. Suspect serum sickness from Tdap. Patient has since recovered.
started crying 2 hrs p/vax, some vomiting; cont w/inconsolable crying while awake for 1 wk; took APAP every 4-6 hrs;
No additional AE; PROQUAD that was inadvertently administered to a patient after a temperature excursion; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported.       On 01-AUG-2023, the patient was inadvertently vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) 0.5ml/once, recombinant Human albumin (rHA) lot # X011980 with expiration date 19-JUL-2024, for prophylaxis (strength, route of administration and anatomical location were not reported). No additional adverse event (AE) was reported. It was stated that the vaccine was exposed to a temperature of -2.2°C for 5 hours and 57 minutes. No previous temperature excursions were reported.
vaccines where administered to patient. After patient left the clinic and vials where going to be discarded, MA noticed that the Rotarix oral applicator used to withdraw diluent was attached to HIB vaccine diluent applicator. As soon as she noticed, she notified the Manager.
PT HAD APPT FOR COVID VACCINE. PRIMARY SERIES WAS PFIZER. PT REPORTED SHE HAD AUTO IMMUNE DISEASE AND WAS IMMUNOCOMPROMISED. PHARMACIST ADMINISTERED FULL DOSE MODERNA 0.5 ML BUT PT SHOULD RECEIVE PFIZER 0.3 ML
48 hours post vax the pt developed a rash. It was noted that the reporter did not ask the pt how many lesions were present or where the rash was located.
patient got shot, went home, got dizzy fell over and hit head, they called their doctor who told them that this was positional vertigo and a rare reaction, patient said they were fine but they just had a nasty head bump
High fever (103), chills, sore muscles, severe outbreak of cold sores on mouth, nose, inside nose and on cheek.
Dizziness, Sedation, Myalgia, Fever, Sweating and skin blotching, shot arm was swollen and sore Narrative:  Noted sore arm and mild headache after initial dose. Received second dose at 1320 on 1/20/21, noted lightheadedness within several hours. At 2030 felt onset of chills. On 1/21/21 reported chills, myalgias all day. Had some diaphoresis and skin looked blotchy. His shot arm was swollen and sore. At 1600 1/21/21 had 102.5 temp and shivers. Lasted throughout the night and into the next day. Treated with acetaminophen and ibuprofen. Symptoms improved on 1/23/21, but noted mild fatigue/malaise. Missed work x 2 days due to symptoms. No known prior COVID infection.  Other Relevant History:
unable to lift arm in active range of motion; difficulty sleeping; administered too high on the arm into the subacromial space; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received the first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: Eh9899), via an unspecified route of administration at the left arm on 18Dec2020 at 15:00 (03:00 PM) at single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination, and the patient has not been tested for COVID-19 since the vaccination. The patient's medical history was not reported (other medical history: yes). The patient had no known allergies. Concomitant medication included other unspecified medications received within 2 weeks of vaccination. The patient reported that the injection was given and she thought that it was administered too high on the arm into the subacromial space. By end of day, she was unable to lift arm in active range of motion, and had difficulty sleeping. Following day, still unable to lift arm. The events unable to lift arm in active range of motion, and had difficulty sleeping started on 18Dec2020 at 16:00 (04:00 PM). The clinical outcome of the events was unknown.
Received FLUMIST Intranasal on 11/19/04 - awoke on 11/20/09 with fever and vomiting. 11/21/09 Flu sx - fever, vomiting, sore throat, Rx TAMIFLU 45 mg BID 5 d. Tested positive Influenza A and B. 11/30/09 Per mfg. - Repeated FLUMIST due to Tx of Tamiflu 48 hours after Flumist 11/30/09. 12/2/09 Sx vomiting/fever/sore throat.
PT reported throat swelling sensation and difficulty to swallow associated with mild chest pressure approx 5 mins after vaccination. Pt denied nausea, sob, rash, voice coarseness. Upon assessment, no redness/edema to throat/tongue , airway patent. No rash observed  Began to report improvement in sx approx 5 mins into oberservation period but still felt some difficulty swallowing.  50mg Benedryl given prophylactically at this time.  Pt free of symptoms at time of discharge w/ boyfriend. d/c vitals : HR:92 RR:18 BP 120/80 SP02: 99%
sore arm (injection site); This spontaneous case was reported by an other health care professional and describes the occurrence of INJECTION SITE PAIN (sore arm (injection site)) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced INJECTION SITE PAIN (sore arm (injection site)). On 28-Feb-2021, INJECTION SITE PAIN (sore arm (injection site)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant product use was not provided. treatment information was not provided   This case was linked to US-MODERNATX, INC.-MOD-2021-064269 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-064269:Case created for events after first dose of Moderna Vaccine
Sore Arm; This is a spontaneous report from a non-contactable Other HCP (patient herself).  This 26-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EN5318), via an unknown route in the left arm, on 26Jan2021 (at the age of 26-year-old) at single dose for COVID-19 immunisation. No other vaccine was received in four weeks. Relevant medical history included COVID-19 (before vaccine). No relevant concomitant medications were provided. On 26Jan2021, the patient had sore arm. The event was reported as non-serious. No treatment was given for the event. Pre and Post vaccination COVID tests were not performed. The patient recovered from the event on unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Vaccine given past the use by date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given past the use by date) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033K21-2A) for COVID-19 vaccination.    Co-suspect product included non-company product DIPHTHERIA VACCINE TOXOID, TETANUS VACCINE TOXOID (TETANUS DIPHTHERIA) for an unknown indication.    It was unknown patient had ever being diagnosed with/ tested positive for COVID-19. Patient had no allergies to medications, food, and other products. Patient had no acute illnesses at the time of vaccination and up to one month before.  Concurrent medical conditions included Type 2 diabetes mellitus, Hypothyroidism and Asthma. Concomitant products included SALBUTAMOL SULFATE (VENTOLIN HFA) for Asthma, LEVOTHYROXINE for Hypothyroidism, ALPRAZOLAM, ESCITALOPRAM, RIZATRIPTAN BENZOATE (MAXALT), VALACICLOVIR HYDROCHLORIDE (VALTREX) and ATORVASTATIN CALCIUM for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Apr-2022 at 9:53 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On an unknown date, the patient received dose of DIPHTHERIA VACCINE TOXOID, TETANUS VACCINE TOXOID (TETANUS DIPHTHERIA) (Intramuscular) 1 dosage form. On 05-Apr-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given past the use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given past the use by date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Anatomical location for the booster dose was reported as right deltoid.  The use by date listed was on 18-Mar-2022.  Vial was initially stored in the refrigerator on 18-Feb-2022 and it was reported that the vial did not undergo ay temperature excursion.  No treatment medication were provided.   This case was linked to MOD-2022-536509 (Patient Link).
she has tested Positive for Covid and she did take the Pfizer vaccine; she took the other vaccine last year; she has tested Positive for Covid and she did take the Pfizer vaccine; she took the other vaccine last year; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 30-year-old female patient received BNT162b2 (BNT162B2), in 2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 29 years for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 01Jun2022, outcome "unknown" and all described as "she has tested Positive for Covid and she did take the Pfizer vaccine; she took the other vaccine last year". The events "she has tested positive for covid and she did take the pfizer vaccine; she took the other vaccine last year" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (01Jun2022) positive.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
had both doses of Shingrix/ 18 months ago/ come down with shingles/ suspected vaccination failure; come down with shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were provided as follows: The case was reported by the patient for himself/herself. The age at vaccination was not reported. The age group was not reported but was captured as an adult as per vaccine indication. The patient received both doses of the Shingrix vaccine about 18 months prior to the reporting date and came down with shingles at the time of reporting. The reporter asked if there was any problem with this vaccine. This case was considered as suspected vaccination failure, since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were not provided.
pt reported feeling light headed, chest pain, flushed face one to two minutes after administration.  Paramedics contacted, who provided oxygen (sat99 hr 60), and transport to local hospital for eval at pt request.
contracted shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (contracted shingles) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced HERPES ZOSTER (contracted shingles). At the time of the report, HERPES ZOSTER (contracted shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Patient presented to the ER with c/o cough and SOB. Patient was noted to be tachypneic and saturating 87% in the ER on room air. Found to be Covid positive and diagnosed with Covid pneumonia. Patient received IV abx, IV steroids, Remdesivir, Lovenox. Patient is on 2L NC PTA and was up to 6L during admission. Patient was discharged to a skilled nursing home.
The next morning, 09:00 am, I had mild flu symptoms which was full body aches and feeling feverish and unwell. I didn't register a fever on the thermometer. I was very tired; no appetite. I stayed resting all day. Slept a lot. It was easy for me to sleep - very unusual. By 9:00 pm that all lifted and I was feeling back to normal. The morning of March 28, I woke up with a very sore throat. And on 3/29, I had really continued sore throat on and off and Tuesday it got much worse. There was a really strange sensation of being extremely thirsty - I had never had experienced that before. Swollen gland on the right side of my throat - between the jaw and ear area. I had a little bit of an earache on the right side. I drove by the drive-in testing area. I am working in person each day so I get the drive by testing - I think Tuesday, the 30th. Called the dr and did the Telehealth visit - Wednesday - the 31st. I had in and out of laryngitis - raspy voice and headache. I looked in my throat with flashlight and could see a definitive red spot in back of throat and some white spots.  They said it could be a blocked salivary gland and told me to eat something very sour to activate it. Over 6 to 8 hours it did clear the issue somewhat - thirst went away. I still had a sore throat. They told me that by the weekend, I could maybe start antibiotic. Saturday night I took first dose of Zpack - two tablets at first dose and then one tablet a day after that. By late evening Sunday (Easter) I felt some relief of symptoms. This week I still have a little bit of raspy voice and post nasal drip and clearing my throat at this point. I am recovering but not fully recovered.
worsen both my pulsatile tinnitus and hyperacusis and hasn't subsided
- following the vaccine i began to develop a very severe sore throat (no cough) that last for up to 5+ days. - body fatigue and weakness ensues and sore throat persists. - constant runny nose after day 4 - burning sensation comes and goes in nostril / sinus cavity  - on day 5 i begin to have severe sinus congestion all throughout my head and face
mom noticed mild rash on legs 7PM on the day shot were given; next morning pt covered w/hives, eyes swollen, fever about 101 ax; seen by MD;